PT - JOURNAL ARTICLE AU - Bai, Yue AU - Safikhani, Abolfazl AU - Michailidis, George TI - Non-stationary Spatio-Temporal Modeling of COVID-19 Progression in The U.S. AID - 10.1101/2020.09.14.20194548 DP - 2020 Jan 01 TA - medRxiv PG - 2020.09.14.20194548 4099 - http://medrxiv.org/content/early/2020/09/18/2020.09.14.20194548.short 4100 - http://medrxiv.org/content/early/2020/09/18/2020.09.14.20194548.full AB - The fast transmission rate of COVID-19 worldwide has made this virus the most important challenge of year 2020. Many mitigation policies have been imposed by the governments at different regional levels (country, state, county, and city) to stop the spread of this virus. Quantifying the effect of such mitigation strategies on the transmission and recovery rates, and predicting the rate of new daily cases are two crucial tasks. In this paper, we propose a modeling framework which not only accounts for such policies but also utilizes the spatial and temporal information to characterize the pattern of COVID-19 progression. Specifically, a piecewise susceptible-infected-recovered (SIR) model is developed while the dates at which the transmission/recover rates change significantly are defined as “break points” in this model. A novel and data-driven algorithm is designed to locate the break points using ideas from fused lasso and thresholding. In order to enhance the forecasting power and to describe additional temporal dependence among the daily number of cases, this model is further coupled with spatial smoothing covariates and vector auto-regressive (VAR) model. The proposed model is applied to several U.S. states and counties, and the results confirm the effect of “stay-at-home orders” and some states’ early “re-openings” by detecting break points close to such events. Further, the model performed satisfactorily short-term forecasts of the number of new daily cases at regional levels by utilizing the estimated spatio-temporal covariance structures. Finally, some theoretical results and empirical performance of the proposed methodology on synthetic data are reported which justify the good performance of the proposed method.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialUsed publicly available data for COVID-19Funding StatementNAAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NA since it was a publicly available dataAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used are publicly available and also can be found in the authors' GitHub page with the link below: https://github.com/ybai69/COVID-19-Change-Point-Detection